We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601696:SSEBOC International (China) Co., Ltd. Class A Analysis

Data as of 2026-03-17 - not real-time

CN¥13.44

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

BOC International is trading close to its recent support level with a neutral price trend and a bearish MACD signal, while the RSI sits in a mid‑range zone, suggesting limited upside momentum in the short run. Technical indicators point to a cautious stance, but the fundamentals tell a different story: revenue is expanding at a robust pace, margins are healthy, and the company holds a substantial cash buffer despite a high debt load. The current price is markedly below the discounted cash‑flow estimate, indicating a potential valuation gap, even though the price‑to‑earnings multiple sits well above the industry average. Dividend yield is modest and the payout ratio is low, supporting dividend sustainability.
Regulatory and geographic considerations in China’s financial sector add a layer of uncertainty, yet the stock benefits from low beta, stable trading volume, and ample liquidity. Investors should weigh the strong growth narrative against the debt‑related risk and the broader policy environment, positioning the stock as a possible medium‑ to long‑term opportunity while remaining cautious in the immediate term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price near technical support
  • bearish MACD histogram
  • mid‑range RSI indicating limited short‑term momentum

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • strong revenue growth and healthy margins
  • significant gap between market price and DCF fair value
  • low dividend payout supporting cash preservation

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • sustained cash reserves despite high leverage
  • growth‑oriented business model in capital markets
  • potential upside as regulatory environment stabilizes

Key Metrics & Analysis

Financial Health

Revenue Growth53.60%
Profit Margin32.91%
P/E Ratio33.6
ROE6.03%
ROA1.33%
Debt/Equity135.78
P/B Ratio2.0
Op. Cash FlowCN¥4.4B
Industry P/E16.5

Technical Analysis

TrendNeutral
RSI43.7
SupportCN¥13.26
ResistanceCN¥14.58
MA 20CN¥13.86
MA 50CN¥14.21
MA 200CN¥13.66
MACDBearish
VolumeStable
Fear & Greed Index79.45

Valuation

Fair ValueCN¥51.26
GradeUndervalued
TypeGrowth
Dividend Yield0.29%

Risk Assessment

Beta0.31
Volatility31.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.